ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

First ‘off-the-shelf’ stem cell therapy gains central authorization in EU – The Pharma Letter

Continue reading

2018-03-23 Michael Zand NEWS

First ‘off-the-shelf’ stem cell therapy gains central authorization in EU – The Pharma Letter


The Pharma Letter

First ‘off-the-shelf’ stem cell therapy gains central authorization in EU
The Pharma Letter
Japanese pharma company Takeda Pharmaceutical (TYO: 4502) and the Belgian biopharma that it is in the process of acquiring, TiGenix, achieved a notable milestone on Friday with the European Commission’s approval of Alofisel (darvadstrocel). It has been …
Stem cell therapy approved in Europe to treat fistulizing Crohn’s diseaseHealio

all 3 news articles »

Continue reading

2018-03-23 Michael Zand NEWS

Synthetic Biology Workstation Market| CAGR of 7.02% from 2018-2022 |Absolute Analysis – Healthcare Journal

Synthetic Biology Workstation Market| CAGR of 7.02% from 2018-2022 |Absolute AnalysisHealthcare JournalSynthetic Biology Workstation Market report provides regional analysis of Americas, APAC, EMEA regions. Synthetic Biology Workstation market report e… Continue reading

2018-03-23 Michael Zand NEWS

Early Results of International Stem Cell Trial for RRMS Show Reduced Relapses, Less Disability – Everyday Health, Inc. (blog)


The Pharma Letter

First ‘off-the-shelf’ stem cell therapy gains central authorization in EU
The Pharma Letter
Japanese pharma company Takeda Pharmaceutical (TYO: 4502) and the Belgian biopharma that it is in the process of acquiring, TiGenix, achieved a notable milestone on Friday with the European Commission’s approval of Alofisel (darvadstrocel). It has been …
Stem cell therapy approved in Europe to treat fistulizing Crohn’s diseaseHealio

all 3 news articles »

Continue reading

2018-03-23 Michael Zand NEWS

Society for Immunotherapy of Cancer to honor Dr. Phil Greenberg – Fred Hutch News Service


Everyday Health, Inc. (blog)

Early Results of International Stem Cell Trial for RRMS Show Reduced Relapses, Less Disability
Everyday Health, Inc. (blog)
Many people with relapsing-remitting multiple sclerosis (RRMS) do well on disease-modifying drugs. For those who don’t, interest in stem cell transplants — either to “reboot” the immune system or to repair damaged myelin — has been growing in recent …

Continue reading

2018-03-23 Michael Zand NEWS

New Gene Therapy For Blindness Comes With Hefty Price Tag – WPSU


Fred Hutch News Service

Society for Immunotherapy of Cancer to honor Dr. Phil Greenberg
Fred Hutch News Service
On Thursday, the Society for Immunotherapy of Cancer announced Dr. Philip Greenberg as the 2018 recipient of the Richard V. Smalley, M.D., Memorial Award and Lectureship, the society’s highest honor. Greenberg is head of the Program in Immunology at …

Continue reading

2018-03-23 Michael Zand NEWS

New Gene Therapy For Blindness Comes With Hefty Price Tag – NPR Illinois | 91.9 UIS

New Gene Therapy For Blindness Comes With Hefty Price Tag
WPSU
Earlier this week doctors in some hospitals began using gene therapy to treat a rare vision disorder that can lead to blindness. The procedure comes with a record-setting price tag — more than $400,000 per eye. Here & Now’s Meghna Chakrabarti learns …

Continue reading

2018-03-23 Michael Zand NEWS

New Gene Therapy For Blindness Comes With Hefty Price Tag – NPR Illinois | 91.9 UIS

New Gene Therapy For Blindness Comes With Hefty Price Tag
NPR Illinois | 91.9 UIS
Earlier this week doctors in some hospitals began using gene therapy to treat a rare vision disorder that can lead to blindness. The procedure comes with a record-setting price tag — more than $400,000 per eye. Here & Now’s Meghna Chakrabarti learns …

and more »

Continue reading

2018-03-23 Michael Zand NEWS
  • 1
  • …
  • 354
  • 355
  • 356
  • 357
  • 358
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

New Gene Therapy For Blindness Comes With Hefty Price Tag
NPR Illinois | 91.9 UIS
Earlier this week doctors in some hospitals began using gene therapy to treat a rare vision disorder that can lead to blindness. The procedure comes with a record-setting price tag — more than $400,000 per eye. Here & Now’s Meghna Chakrabarti learns …

and more »